Showing results (1411-1420 of 1,560) with videos related to

Sort By:
Pageof 156
Urology|April 10, 2004
Long-term pooled analysis of multicenter studies of cooled thermotherapy for benign prostatic hyperplasia results at three months through four yearsBruce J Trock, Michelle Brotzman, William J Utz, et al.
European Urology|July 25, 2016
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysisMauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al.
Clinical Pharmacology and Therapeutics|September 1, 1980
Influence of phenytoin and phenobarbital on the disposition of a single oral dose of clonazepamK C Khoo, J Mendels, M Rothbart, et al.
Voprosy Onkologii|January 12, 2000
[The potential of rose Bengal treatment for photodynamic therapy of tumors]M A Kaplan, R G Nikitina, A I Malygina, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1980
The spectrum of left main coronary artery disease: variables affecting patient selection, management, and deathE L Jones, S B King, J M Craver, et al.
Journal of Lipid Mediators|May 1, 1993
Pharmacological profile of epiyangambin: a furofuran lignan with PAF antagonist activityH C Castro-Faria-Neto, M A Martins, P M Silva, et al.
The Journal of Urology|June 23, 2009
Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health SurveyVarant Kupelian, Kevin T McVary, Steven A Kaplan, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1978
Pharmacokinetics of flunitrazepam following single- and multiple-dose oral administration to healthy human subjectsH G Boxenbaum, H N Posmanter, T Macasieb, et al.
Cancer Gene Therapy|July 6, 2000
Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancerA Hasenburg, X W Tong, A Rojas-Martinez, et al.
The Journal of Urology|January 3, 2020
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)Steven A Kaplan, Sender Herschorn, Kevin T McVary, et al.
Pageof 156